目前,各项价格改革正在迅速推进,而医药价格改革进度缓慢,国家定价品种较多,办法老化,与市场经济发展的要求不符.在国家和各省的管价目录中有的提法比较笼统,如“部分中西药”.医药价格究竟如何改革,“部分中西药”应该如何理解,应实施何种管理办法等,都有待研究解决.本文试图结合河南省的实际回答以上问题. At present, various price reforms are rapidly advancing, and the progress of pharmaceutical price reforms is slow. There are many types of state pricing, and the methods are aging, which are inconsistent with the requirements of market economy development. There are references in the list of national and provincial prices, which are more general. For example, how to reform “partial Chinese and Western medicines” or “medicine prices”, “how some parts of Chinese and Western medicines” should be understood, and what kinds of management methods should be implemented, etc., are pending research and resolution. This article attempts to combine Henan province’s actual answers to the above questions.